Qiagen NV
Spoorstraat 50
Venlo,
5911 KJ
Netherlands - Map
Phone: 31 77 320 8400
Fax: 31 77 320 8409
Web Site: http://www1.qiagen.com
| Qiagen N.V. provides technologies and products for preanalytical sample preparation and linked molecular assay solutions worldwide. Its sample technologies are used to collect, stabilize, isolate, and purify deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins from blood, bone, and tissue samples; and assay technologies are used to make specific target biomolecules, such as the DNA of a specific virus for subsequent detection and analysis. The company offers sample and assay consumable products that are used in plasmid, DNA purification; RNA purification and stabilization; genomic and viral nucleic acid purification; nucleic acid transfection; polymerase chain reaction (PCR) amplification; reverse transcription; DNA cleanup after PCR and sequencing; and DNA cloning and protein purification. It also provides PCR assays, which allow PCR-based detection of viral, bacterial and parasite, human, and animal pathogens, as well as pharmacogenomic genotyping; and various other products for research in the areas of epigenetics, gene expression, micro RNA, proteomics, RNAi, and applied testing and molecular diagnostics. In addition, the company offers automated systems that provide walk-away automation of sample and assay technologies in low, medium, or high throughput scale, as well as reaction set-up and other laboratory tasks; QIAcube, which allows users in research in life sciences, applied testing, and molecular diagnostic to automate the processing of the companys consumable products; and instruments to OEM partners. Further, it provides custom services, such as whole genome amplification services, DNA sequencing, and non-cGMP DNA production on a contract basis; and sells and/or licenses technology. The company serves researchers at pharmaceutical and biotechnology companies, academic institutions, and government and private laboratories. Qiagen N.V. was founded in 1986 and is headquartered in Venlo, the Netherlands. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Peer M. Schatz , 43
Chairman of Management Board, Chief Exec. Officer, Managing Director, Sec., Treasurer and Chairman of Exec. Committee |
N/A
| N/A | Dr. Metin Colpan Ph.D., 53
Co-Founder, Sr. Technology Advisor and Supervisory Director |
N/A
| N/A | Prof. Dr. Detlev Riesner , 67
Co-Founder, Chairman of the Supervisory Board and Chairman of Selection & Appointment Committee |
N/A
| N/A | Mr. Roland Sackers , 41
Chief Financial Officer, Managing Director and Member of Management Board |
N/A
| N/A | Mr. Bernd Uder , 52
Managing Director, Sr. VP of Global Sales and Member of Management Board |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
1.48% Nasdaq 
0.02 (0.09%) 
Profile
